At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
Comfilcon A (test) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Bilateral Dispensing Comparison of Biofinity Toric and Acuvue Vita for Astigmatism
In Brief
A clinical study evaluating Comfilcon A (test) and Senofilcon C (control) for Astigmatism Bilateral. Completed, enrolled 45 participants across 1 site.
Detailed Summary
The aim of this study is to evaluate the subjective acceptance of Comfilcon A contact lenses when worn on a daily wear modality over one month.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAstigmatism Bilateral
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
First PostedSep 2018
Primary CompletionDec 2018
Study CompletionFeb 2019
TodayJul 2026
First PostedSep 26, 2018
Enrollment StartJul 23, 2018
Primary CompletionDec 14, 2018
Study CompletionFeb 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.8 years ago
Interventions
Comfilcon A (test)device
Daily wear contact lenses
Senofilcon C (control)device
Daily wear contact lenses